Biomedical Aspects of Drug Targeting
Editat de Vladimir R. Muzykantov, Vladimir P. Torchilinen Limba Engleză Hardback – 28 feb 2003
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 1098.69 lei 6-8 săpt. | |
Springer Us – 6 dec 2010 | 1098.69 lei 6-8 săpt. | |
Hardback (1) | 1106.13 lei 6-8 săpt. | |
Springer Us – 28 feb 2003 | 1106.13 lei 6-8 săpt. |
Preț: 1106.13 lei
Preț vechi: 1164.36 lei
-5% Nou
Puncte Express: 1659
Preț estimativ în valută:
211.81€ • 218.25$ • 177.74£
211.81€ • 218.25$ • 177.74£
Carte tipărită la comandă
Livrare economică 22 februarie-08 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781402072321
ISBN-10: 1402072325
Pagini: 532
Ilustrații: XVII, 506 p.
Dimensiuni: 155 x 235 x 34 mm
Greutate: 0.92 kg
Ediția:2002
Editura: Springer Us
Colecția Springer
Locul publicării:New York, NY, United States
ISBN-10: 1402072325
Pagini: 532
Ilustrații: XVII, 506 p.
Dimensiuni: 155 x 235 x 34 mm
Greutate: 0.92 kg
Ediția:2002
Editura: Springer Us
Colecția Springer
Locul publicării:New York, NY, United States
Public țintă
ResearchCuprins
Section 1: General Principles of Drug Targeting.- 1 Strategies and Means for Drug Targeting: An Overview.- 2 Biological Barriers for Drug Targeting.- Section 2: Cardiovascular Targeting.- 3 Targeting the Pathological Myocardium.- 4 Targeting Atherosclerotic Plaques.- 5 Thrombus Targeting of Plasminogen Activators and Anticoagulants.- 6 Tissue-Specific Pharmacodelivery and Overcoming Key Cell Barriers in Vivo: Vascular Targeting of Calveolae.- 7 Targeting Pulmonary Endothelium.- 8 Targeting Inflammation.- 9 Intravascular Re-Targeting of Viral Vectors.- Section 3: Tumor Targeting.- 10 Polymer-Drug Conjugates: Targeting Cancer.- 11 Enhanced Permeability and Retention (EPR) Effect: Basis for Drug Targeting to Tumor.- 12 Ligand-Directed Destruction of Tumor Vasculature.- 13 Tumor Necrosis Treatment and Imaging of Solid Tumors.- 14 Targeted Apoptosis: Antibodies Linked to Rna Damaging Agents.- 15 Immunotoxins and Antibody-Drug Conjugates for Cancer Treatment.- Section 4: Targeting to Brain.- 16 Blood-Brain Barrier Transport and Drug Targeting to the Brain.- 17 LDL-Receptor Mediated Drug Targeting to Malignant Tumors in the Brain.- 18 Targeting Brain Trauma and Stroke.- 19 Targeting Drugs Into the Central Nervous System.- Section 5: Miscellaneous, New Horizons in Targeting.- 20 Strategies for Targeting Infection.- 21 Anti-HIV Immunotoxins.- 22 Ligand-Mediated Gastrointestinal Targeting.- 23 Transmembrane Targeting of Dna with Membrane Active Peptides.- 24 Polymersomes: A New Platform for Drug Targeting.- 25 Targeting Mitochondria.